Helmholtz Gemeinschaft

Search
Browse
Statistics
Feeds

Enhancing biomarker based oncology trial matching using large language models

[thumbnail of Original Article]
Preview
PDF (Original Article) - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
958kB
[thumbnail of Supplementary Information] Other (Supplementary Information)
2MB

Item Type:Article
Title:Enhancing biomarker based oncology trial matching using large language models
Creators Name:Al Khoury, N., Shaik, M., Wurmus, R. and Akalin, A.
Abstract:Clinical trials are an essential component of drug development for new cancer treatments, yet the information required to determine a patient’s eligibility for enrollment is scattered in large amounts of unstructured text. Genomic biomarkers are especially important in precision medicine and targeted therapies, making them essential for matching patients to appropriate trials. Large language models (LLMs) offer a promising solution for extracting this information from clinical trial study descriptions (e.g., brief summary, eligibility criteria), aiding in identifying suitable patient matches in downstream applications. In this study, we explore various strategies for extracting genetic biomarkers from oncology trials. Therefore, our focus is on structuring unstructured clinical trial data, not processing individual patient records. Our results show that open-source language models, when applied out-of-the-box, effectively capture complex logical expressions and structure genomic biomarkers, outperforming closed-source models such as GPT-4. Furthermore, fine-tuning these open-source models with additional data significantly enhances their performance.
Source:NPJ Digital Medicine
ISSN:2398-6352
Publisher:Springer Nature
Volume:8
Number:1
Page Range:250
Date:6 May 2025
Official Publication:https://doi.org/10.1038/s41746-025-01673-4
PubMed:View item in PubMed

Repository Staff Only: item control page

Downloads

Downloads per month over past year

Open Access
MDC Library